跳至主要内容
临床试验/NCT03674853
NCT03674853已完成不适用

Clinical Study of Wuling Capsule in the Treatment of Chronic Tinnitus With Emotional Disorder

Xijing Hospital1 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2018年6月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
59
试验地点
1
主要终点
the change of severity of tinnitus

研究概览

简要总结

To evaluate the effect of psychological/mental factors on the severity of subjective tinnitus, to observe the efficacy and safety of Wuling capsule in the treatment of chronic subjective tinnitus with emotional disorders, and to evaluate the control rate of tinnitus complications, such as depression, anxiety and insomnia, and the improvement of patients'quality of life.

详细描述

To evaluate the effect of psychological/mental factors on the severity of subjective tinnitus, to observe the efficacy and safety of Wuling capsule in the treatment of chronic subjective tinnitus with emotional disorders, and to evaluate the control rate of tinnitus complications, such as depression, anxiety and insomnia, and the improvement of patients'quality of life. Patients with chronic tinnitus complicated with mild to moderate anxiety or depression were randomly divided into two groups. The experimental group was given oral treatment with Wuling capsule, and the control group was given gurusu treatment. The improvement of tinnitus, sleep, anxiety and depression in patients was evaluated at 2,4 and 8 weeks after treatment, respectively, and the efficacy of Wuling capsule in improving tinnitus combined with anxiety, depression and tinnitus was analyzed。

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Tinnitus with a history longer than 6 months;
  • 7 < HAMD score < 24 and / or 7 < HAMA score < 21;
  • No antianxiety, depression or antipsychotic treatment within 2 weeks.

排除标准

  • objective tinnitus;
  • tinnitus with defined causes;
  • accompanied with acute infection, acute trauma, perioperative, chronic disease in the acute stage;
  • with mental illness family history;
  • HAMD score greater than 24 points or HAMA score greater than 21 points;

研究组 & 干预措施

Wuling Capsule group

Experimental

Patients who were treated with Wuling Caspule

干预措施: Wuling Capsule (Drug)

Oryzanol group

Active Comparator

Patients who were treated with oryzanol

干预措施: Oryzanol (Drug)

结局指标

主要结局

the change of severity of tinnitus

时间窗: 8 weeks

tinnitus handicap index is to evaluate the severity of tinnitus

次要结局

  • the change of anxiety level(8 weeks)
  • the change of depression level(8 weeks)

研究者

发起方
Xijing Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验